INTRODUCTION
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referred to as bacterial vaginosis (BV), is characterized lactobacilli and massive overgrowth of Gardnerella vaginalis and other Gram positive and negative anaerobic bacteria (Marrazzo, 2004) . Of concern are recent observations that BV predisposes to acquisition of sexually transmitted infections (STIs), which raises the risk of mother-to-child transmission of human immunodeficiency virus (HIV). Diminished colonisation resistance during BV renders women vulnerable to various infections such as Trichomonas vaginalis and Neisseria gonorrhoeae (Martin et al., 1999; Wiesenfeld et al., 2003) , Chlamydia trachomatis (Wiesenfeld et al., 2003) , genital herpes simplex (Kaul et al., 2007) , human papillomavirus (Watts et al., 2006) and HIV-1 (Spear et al., 2007; Atashili et al., 2008) . Further, it is documented that BV propagates replication and vaginal shedding of the HIV-1 (Sha et al., 2005) and HSV-2 viruses (Cherpes et al., 2005) , thus enhancing the spread of STIs.
Increased mother-to-child transmission of HIV as a consequence of BV has been documented in a prospective study of 463 HIV-1-infected mothers and infants in Kenya (Farquhar et al., 2010) . This study found women with BV to be three times more likely to transmit HIV in utero. High prevalence of BV in sub-Saharan Africa (Sewankambo et al., 1997; Taha et al., 1998; Paxton et al., 1998; Martin et al., 1999; van de Wijgert et al., 2000; Demba et al., 2005; Morison et al., 2005; Bukusi et al., 2006; McClelland et al., 2009 ) has therefore become an issue of global concern. It is estimated, for instance, that in endemic areas, nearly one-third of new HIV cases could be prevented if existing BV were cured (Schwebke, 2005) . Tackling the HIV burden through eradicating BV and restoring normal vaginal microflora is currently considered part of the most promising answers to the HIV pandemic (Martin et al., 1999; Shin and Kaul, 2008; Bolton et al., 2008) . The last two decades have seen a significant increase in the volume of research focusing on BV and composition of vaginal microflora (Verhelst et al., 2005; Kalra et al., 2007; Srinivasan et al., 2010; Verstraelen et al., 2010) . The prevalence of BV varies widely in different populations. It tends to be high in African women, with rates up to 44% having been documented in a Kenyan cohort and 50% in rural Uganda (Paxton et al., 1998; Bukusi et al., 2006) . Studies found African American women to have more than two-fold higher prevalence of BV compared to Caucasian American women. The cause of this disparity remains unknown (Goldenberg et al., 1996; Pastore et al., 1999; Royce et al., 1999; Ness et al., 2003; Allsworth and Peipert, 2007) . Studies show African women to be either less likely to harbor H 2 O 2 -producing lactobacilli which are known to suppress growth of anaerobic bacteria (Antonio et al., 1999) or to have lower concentrations of the same (Anukam et al., 2006; Zhou et al., 2007; McClelland et al., 2009) . African women also tend to have significantly higher vaginal pH than do Caucasian women . In addition, the prevalence of BV has been shown to be higher in HIV-infected women compared to HIVuninfected women (Sewankambo et al., 1997; Jamieson et al., 2001; Warren et al., 2001) . From the foregoing information, it is apparent that more studies are needed to complete our understanding of BV in affected subpopulations. Further, it is not known how vaginal microflora varies during the phases of the menstrual cycle.
The goal of the present study was to investigate the composition of vaginal microflora of non-pregnant premenopausal HIV + and HIV -women in a sub-urban population of Kenya by PCR-based identification of culture isolates obtained during the follicular and ovulation phases of the normal menstrual cycle.
MATERIALS AND METHODS

Study population
This was a cross-sectional study nested in an on-going Tigoni dysplasia study (TDS) based at Tigoni Hospital, Kiambu West district of Kenya. Recruitment of participants took place at the hospital between August 2006 and March 2008. Of the 215 women screened, 100 of them met the inclusion criteria, and only 74 returned for the scheduled six follow-up visits. Specimens were collected at three points of two consecutive menstrual cyclesfollicular (day 5-8), ovulation (day 12-15) and luteal (day 19-22) phases. At each phase, the sampling period was spread out within four days to create flexibility for return visits. The participants were asked to mark all the days of menstrual bleeding as a guide to establishing the regularity of the cycle. Following verbal explanation of the study objectives, written consent to participate was obtained for all participants and hard copies of the study explanation issued to them. The documents were available in both English and the most widely used local language, Kiswahili. The study was approved by the ethical review board of Kenyatta National Hospital/ University of Nairobi (Registration number P122/8/2005) .
During the study, all STIs diagnosed were treated according to the Kenya Ministry of Health national guidelines (2007) WHO guidelines (1997) . Qualifying premenopausal women, aged between 18 and 45 years were screened for eligibility using a standard face-to-face questionnaire interview. The HIV + women who had CD4 counts above 250 cells/mm 3 and not undergoing ART were recruited. All the participants had regular menses and a documented normal papanicolaou (pap) smear test result performed within one year.
The exclusion criteria were presence of STIs, ongoing pregnancy, use of contraception except condom, previous hysterectomy, delivery or abortion in the preceding three months and use of systemic antibiotics (except cotrimoxazole prophylaxis for HIV + women given under Kenya national guidelines for HIV management). The HIV test was performed in order to group patients as positive and negative.
Following the face-to-face questionnaire interview, subjects provided blood specimens for HIV testing, syphilis and CD4 count. Vaginal specimens were taken to test for T. vaginalis, C. trachomatis and N. gonorrhoeae. HIV pre-and post-test counselling was offered by a trained nurse.
Screening tests
Study participants were screened for HIV-1 infection using enzymelinked immunosorbent assay (ELISA) Detect-HIV (BioChem ImmunoSystems, Allentown, PA). Positive samples were confirmed by a second ELISA (Vironostika, BioMérieux, Marnes-la-Coquette, France) (WHO guidelines). Urine pregnancy test was performed using a rapid β-hCG test kit (Plasmatec Laboratory products, Cambridge, UK) and syphilis seroreactivity assessed by the Rapid Plasma Reagin (Becton Dickinson, Baltimore, MD). Confirmatory Treponema pallidum haemagglutination assay was not necessary as no seroreactive cases were detected. Two high vaginal swabs were taken for T. vaginalis culture (In-Pouch, Biomed Diagnostics, San Jose, CA) and for diagnosis of candidiasis assessed by microscopic examination for presence of budding yeasts or pseudohyphae in a drop of 10% KOH. One endocervical swab was required for combined C. trachomatis and N. gonorrhoeae polymerase chain reaction (PCR) (Cobas Amplicor, Roche Diagnostics, Basel, Switzerland). The CD4 count was performed by flow cytometry using specific antibodies (Becton Dickinson), and stained samples analysed using a FacsCaliber instrument and the CELLQuest Software (Becton Dickinson).
Follow-up sample collection
The 74 women (41 HIV + and 33 HIV -) followed up had two high vaginal swabs taken at subsequent visits as follows: with a nonlubricated speculum in place, sterile cotton swabs were consecutively inserted into the vaginal vault. Each swab was rotated against the lateral vaginal wall at the mid-portion of the vault and carefully removed to prevent contamination with the vulva and introitus microflora. The first swab was used to make a Gram stain. The second swab was carried to the laboratory in Amies transport medium (Nuova Aptaca, Canelli, Italy) for anaerobic culture which was performed at follicular (day 5-8) and ovulation (day 12-15) phases. Culture swabs were processed in the microbiology laboratory within 4 h of collection. Gram stain specimens were analysed for the composition of the vaginal microflora by microscopy according to the Nugent criteria (Nugent et al., 1991 ). An additional category of the gram stains known as grade 0 was included to represent the smears lacking bacteria cells.
Culture and identification of isolates
The swabs were streaked onto Columbia agar (Becton Dickinson) supplemented with 5% sheep blood (obtained freshly defibrinated from the Kabete Veterinary farm, University of Nairobi, Kenya) and incubated anaerobically (GasPak EZ Anaerobe Container System) at 37°C. After 4 days of incubation, all isolates with different colony morphology were selected for species identification. DNA was extracted by simple alkaline lysis as follows: each colony selected for its unique morphology was suspended in 20 µl sodium dodecyl sulfate (SDS) lysis buffer (0.25% sodiumdodecylsulphate in 0.05 N NaOH), heated at 95°C for 15 min and diluted with 180 µl double distilled water. The t-DNA-PCR and capillary electrophoresis were carried out as described previously (Baele et al., 2000; Baele et al., 2002) . Species identification of culture isolates was achieved by comparing their respective t-DNA-PCR fingerprints with an existing t-DNA-PCR database using an in-house software program (Baele et al., 2002) . The t-DNA-PCR fingerprint database and the software are available upon request to Laboratory for Bacteriology Research, Ghent University, Belgium, where the PCR work was carried out. Isolates that could not be identified in the existing t-DNA-PCR database were sequenced as earlier described (Verhelst et al., 2004) .
Statistical analysis
Prevalence rates were compared between groups through Chisquare test or Fischer's Exact Test. Statistical significance was accepted at the significance level α=0.05. All analyses were performed with statistical software package PASW v18.0 (Chicago, IL).
RESULTS
Cohort characteristics
Baseline demographic characteristics of 41 HIV + and 33 HIV -women are presented in Table 1 . All participants were literate and able to follow the appointment schedule. At enrolment, no significant difference existed in most parameters measured in the two groups. The HIV + women had lower CD 4 counts (p<0.001) and condom use was more common among them (61%) compared to the HIV -women (18.2%) (p=0.0002). Intake of antibiotic prophylaxis was only in the HIV + group at 78% (p<0.001). The Kenya national guidelines for treatment and care for HIV persons allows continuous antibiotic intake for prevention of malaria and recurrent bacterial infections. Of the HIV + participants, 63.4% were married compared to 39.4% HIV -ones (p=0.001). The HIV + women had lower levels of schooling (p=0.005).
Vaginal microflora and HIV status
Bacterial vaginosis was diagnosed in 17.5% enrolment visits. Table 2 shows the fluctuation in Gram stain score over two menstrual cycles. Respectively 42.4% of HIV -and 31.7% of HIV + women harboured a normal vaginal microflora on all six visits. As shown in Table 3 , the number of vaginal swabs with grades I, II and III was similar throughout the phases of the menstrual cycle in both study groups.
Presence of bacterial species according to HIV status
Species cultured and identified in the HIV + and HIV -women are presented in Table 4 and Figure 1 . In total, 1020 isolates were cultured. Of these, 26% of the isolates remained unidentified either because no corresponding t-DNA-PCR fingerprint was found in the existing database or no amplification obtained. In total, 51 species were identified, nine of which belonged to the genus visits for two women and it occurred twice in five women and once in 11 women. Lactobacillus iners was cultured on three visits for two women, twice in two women and only once in 13 women. Lactobacillus jensenii was recovered on three out of four visits in five women, on two visits in two women and one visit in four women. Two species occurred more frequently in the HIV+ women compared to HIV-women: L. iners (15.5% vs 6.5%; p=0.02) and L. jensenii (13.4% vs 4.6%; p=0.01). G. vaginalis and P. lacrimalis occurred more frequently in HIV + women (respectively 12% vs 3.7% and 7% vs 0.9%; p=0.01). D. micraerophilus was found more frequently in the HIV -group (3.7% vs 0%; p=0.02) as was S.
agalactiae (12% vs 4.9%; p=0.04).
DISCUSSION
The objective of this study was to compare vaginal microflora of HIV + and HIV -Kenyan women of reproductive age by means of culture and Nugent scoring of Gram stains. There were existing differences in the species present in the two groups of women. This confirms findings of Spear et al. ( 2008) who identified a trend towards increased diversity in HIV + women, suggesting that HIV infection may be associated with changes in the diversity of genital microflora.
Presence of BV has been associated with increased susceptibility to acquisition of STIs (Martin et al., 1999; Sewankambo et al., 1997; Kaul et al., 2007) . Since BV increases the risk of HIV acquisition, it would be expected that higher rates of BV be confirmed among HIV + women. However, in this study, no significant difference was found in the rates of BV in HIV + and HIV -women. This agrees with findings of Demba et al. (2005) and Watts et al. (2006) , but is in contradiction to observation of other researchers Sewankambo et al., 1997; Warren et al., 2001 ) who found prevalence of BV to be higher among HIV-infected women compared to HIVuninfected women.
Possible explanation for the lack of correlation between the prevalence of BV and HIV status observed in the current study may be due to differences in antibiotic intake between HIV + and HIV -women. The imbalance of vaginal microflora in this HIV + group may further be explained by the fact that 78% of them were on cotrimoxazole (trimethoprim-sulfamethoxazole) prophylaxis. Although this antibiotic has been shown to reduce mortality of HIV patients and to have a beneficial effect by decreasing the rate of CD 4 cell depletion (Mermin et al., 2004 ), use of antibiotics decimates H 2 O 2 -producing lactobacilli in the vagina (Vallor et al., 2001; Hummelen et al., 2010) . Co-trimoxazole is the prophylaxis antibiotic approved by the Kenya Ministry of Health (2007) and is readily available to HIV + persons in health centers. It is used similarly in other sub-Saharan African countries (Hamer and Gill, 2008) . Since the HIV + women continue to have more lactobacilli despite continuous intake of cotrimoxazole, it is suggested that resistance to this antibiotic may have been attained. A previous study found that women with BV have decreased colonization rates for H 2 O 2 -producing strains of lactobacilli and increased colonization rates for non-H 2 O 2 -producing strains (Onderdonk et al., 2003; Ferris et al., 2007) . This observation is supported by the present findings that L. iners, G. vaginalis and P. lacrimalis occurred more frequently in HIV + women regularly using antibiotics. Some studies found infection with HIV-1 to be associated with abnormal vaginal microflora. Sewankambo et al. (1997) who studied 4718 women in a community survey in rural Uganda, concluded that loss of lactobacilli or presence of BV may increase susceptibility to acquisition of HIV-1. Jamieson et al. (2001) and Warren et al. (2001) while studying different aspects of a comparable high-risk cohort of 1288 women in the USA, found HIV infection to be positively correlated with presence of BV. However, they could not determine whether HIV-infected women have a higher incidence of BV or more persistent infections. Participants of the said study were not excluded on account of low CD 4 counts or other STIs like in the current one. Jamieson et al. (2001) found that immunocompromised women (CD 4 cell count < 200 cells/μL) were more likely to have prevalent and persistent BV than HIV-infected women with higher CD 4 cell counts (>500 cells/μL), but not more likely to have incident infections. This could be explained by the fact that the immunocompromised women were probably on HAART and the accompanying cotrimoxazole prophylaxis (Hamer and Gill, 2008; Watts et al., 2006 ). In the current cohort, none of the 74 women were immunocompromised or on ART, as illustrated by the fact that, of the 41 HIV + women, 56.1% had CD 4 cell count in the range 250-500 cells/μL and the rest in the range 501-1500 cells/μL.
Further to the differences in immune status and therapeutic intervention between the two study groups, differences in sexual dynamics may also play a role. At the time of the study, most of the HIV-infected women had one (75.6%) or no (24.4%) sexual partners while 63.4% were married. This may partly explain why no differences were detected in the prevalence of BV between the HIV-infected and uninfected subjects. Confounders not measured but varying between populations may also contribute to the difference in findings. In the current study more HIV + women were married, which may imply that marriage increased the risk of exposure to HIV infection in this population. This finding is consistent with data obtained by the Kenya Aids Indicator Survey (KAIS, 2007) . Compared to the HIV -group, the HIV + women had lower levels of schooling, which may contribute to the observed lower rate of formal employment of HIV + women (24.4% compared to 42.4% HIV -women). A previous study in Kenya (Steele et al., 2004) found genital hygiene practices to be associated with resource access factors such as higher education and income. Further, a more recent study clearly shows low socio-economic status to be associated with prevalence of BV in African American women (Allsworth and Peipert, 2007) . The presence of BV is believed to predispose women to acquisition of HIV-1 (Sewankambo et al., 1997) , whereas the psychosocial stress created by being HIV infected could predispose to acquisition of BV (Nansel et al., 2005) , thus creating a complex interrelationship between the two infections.
In agreement with other culture-based studies of African populations (Martin et al., 1999; McClelland et al., 2009) , the concentrations of vaginal Lactobacillus species were comparatively low, and prevalence of abnormal vaginal microflora and BV-associated species high in the current study group. High rates of BV were previously observed in cohorts of African women (Sewankambo et al., 1997; Taha et al., 1998) and in Kenya (Bukusi et al., 2006; McClelland et al., 2009 ). It appears, therefore, that African women have lower concentration of lactobacilli in their vaginal microflora, which may explain the high rates of BV in this population. Reasons for this are unclear, although vaginal hygiene practices and sexual behaviour may play a role. No significant effect of the menstrual cycle on the prevalence of BV was observed. Earlier studies found quantities of lactobacilli to decrease during menstruation (Keane et al., 1997) and vaginal microflora to be more unstable during the first week . The current study found almost equal numbers of grade I to III samples evenly spread out in the three sampling points at follicular (day 5-8), ovulation (day 12-15) and luteal (day 19-22) phases. This difference in observations may be explained by the varying time frame of sample collection in the current study. Keane et al. (1997) had a daily collection of the vaginal swabs while Morison et al. (2005) collected a sample on alternate days. As recent report by showed that episodes of BV may be missed if specimens are collected at weekly or monthly intervals since fluctuations occur more frequently, and in some episodes remission may occur without intervention. However the current study had the strength of having accounted for most known behavioural confounders commonly associated with increased dynamism of the vaginal microflora (such as age, douching, contraceptive use, vaginal lubricants, irregular condom use, STIs and multiple partners) (Schwebke et al., 1999) . This makes the observation of almost equal numbers of grade I to III samples evenly spread out in the three sampling points of the menstrual cycle more reliable. Demba et al. (2005) , also using culture methods, found Prevotella and Bacteroides species to occur more frequently in Nigerian HIV + women. The current study found these species to be equally distributed among both HIV + and HIV -groups. Other bacteria isolated in the vaginas of the participants that are not associated with normal vaginal microflora include the streptococci. S. agalactiae was most common in the HIV -group. Most of the other species identified occurred at more or less the same frequency in the two groups, and in other cases where a species was altogether absent in one group, statistical significance in the differences was not attained.
The finding that the most abundant Lactobacillus species in the grade I category were L. iners (17.1%), L. crispatus (16.4%), L. jensenii (12.5%) and L. vaginalis (9.2%), in that order, are largely in agreement with previous studies of African women. In Nigeria, using denaturing gradient gel electrophoresis, one group (Anukam et al., 2006) found L. iners and L. gasseri to be the predominant species while in Uganda others (Jin et al., 2007) found L. reuteri, L. crispatus, L. vaginalis and L. jensenii to be most abundant using culture and PCR identification as in the current study. A more recent study conducted in Kenya (Matu et al., 2009) found L. jensenii to be the most abundant species using culture and phenotypic identification methods. In Belgian women, L. iners is more dominant in altered vaginal microflora (De Backer et al., 2007) . One group (Anukam et al., 2005; Anukam et al., 2006) did not however detect lactobacilli in BV cases whereas in the current study, of the nine Lactobacillus species detected, eight of them were present in the non-grade I samples. The causes of racial difference in concentrations of lactobacilli remain unknown. A highly intriguing observation came from a study of Nigerian women (Anukam et al., 2006 ) that found only 3% of the healthy vaginal microflora to be dominated by L. crispatus, while L. iners was present in 64%. Overall African women tend to have lower concentrations of lactobacilli (McClelland et al., 2009 ). This observation may be a possible explanation for the high prevalence of BV among African women (Allsworth and Peipert, 2007; Bukusi et al., 2006) since it is known that most L. iners strains are very weak H 2 O 2 producers. In contrast, L. crispatus is known to produce large amounts of H 2 O 2 and as such provides better colonization resistance (Antonio et al., 1999; Vallor et al., 2001; Verstraelen et al., 2009; Verstraelen et al., 2010) .
Low concentrations of lactobacilli in Kenyan women have been observed by other researchers (McClelland et al., 2009) . Further, among 185 and 241 Nigerian women respectively, two studies found 12 and 10 Lactobacillus spp. to be present (Anukam et al., 2005; Anukam et al., 2006 ). An earlier study comparing Korean and Ugandan women found that vaginal microflora may vary in women of different geographical communities (Jin et al., 2007) . In a US study African American women with BV were found to be predominantly colonized by Mobiluncus spp., based on gram staining . Researchers in Nigeria (Anukam et al., 2006) and The Gambia found Mycoplasma hominis to be commonly associated with BV. In the present study Mobiluncus spp. was cultured in only one subject in the non-grade I category despite the observation of Mobiluncus-like organisms in the vaginal Gram-stained smears. M. hominis was not cultured at all. Although this could point to culture bias, the Demba group )also failed to isolate Mobiluncus in the Nigerian population of 277 women using a 72 h incubation protocol. Like their group, the current study used Columbia blood agar and longer incubations of 96 h.
Some species identified in greater proportions in either the HIV + or HIV -women did not attain statistical significance due to small sample size. Studies of this nature conducted on a larger sample size will help to draw conclusions on other types of microflora predominant in HIV + and HIV -women, thus enabling more specific approaches to probiotic therapy. Probiotic therapy may need to be geographically determined in order to take care of differences in the species and populations of Lactobacillus. Treating BV in HIV + women would subsequently reduce the risk of mother-to-childtransmission.
Conclusions
The current data provide evidence that differences exist in the species that colonize the vaginas of HIV + and HIV -women in the course of the normal menstrual cycle. BV was equally high in HIV + and HIV -women. Lactobacillus and BV-associated species were cultured more frequently in HIV + women. Predominant Lactobacillus in culture were L. crispatus, L. iners, L. jensenii and L. vaginalis. These Kenyan women had lower concentrations of lactobacilli in vaginal microflora than observed
